Live from the NIH registry
Studies recruiting near Baton Rouge right now
Top 25 of 221 recruiting studies, sorted by proximity — each links to its official registry page
Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)
Dementia of Alzheimer Type
N/A
Interventional 144 participants sought
Pennington Biomedical Research — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pennington Biomedical Research Center
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 410 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AVEO Pharmaceuticals, Inc.
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Pennington Biomedical Research Center /ID# 262390 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AbbVie
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Our Lady of the Lake RMC — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Eli Lilly and Company
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Nutrition for Precision Health, Powered by the All of Us
Nutrition, Health
N/A
Interventional 8,000 participants sought
Pennington Biomedical Research Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: RTI International
GLP-1R Actions on Muscle and the Skeleton
Musculoskeletal Abnormalities, Obesity
Phase 4
Interventional 50 participants sought
Pennington Biomedical Research Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pennington Biomedical Research Center
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Plasma Cell Leukemia
Phase 2
Interventional 74 participants sought
Our Lady of the Lake Physician Group — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: NRG Oncology
Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
Obesity
N/A
Interventional 70 participants sought
Pennington Biomedical Research Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AdventHealth Translational Research Institute
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Prairieville, Louisiana (13.5 mi)
· Sponsor: Axsome Therapeutics, Inc.
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Retroperitoneal Sarcoma, Liposarcoma
Phase 3
Interventional 250 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Gilead Sciences
R61/33 - VR Study Phase 4
Attention Deficit Hyperactivity Disorder
Phase 4
Interventional 252 participants sought
Louisiana State University — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Rutgers, The State University of New Jersey
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Gastrointestinal Neoplasms
Phase 3
Interventional 450 participants sought
GSK Investigational Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: GlaxoSmithKline
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research - Baton Rouge — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pfizer
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 40 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Merus B.V.
A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
Obesity
Phase 1
Interventional 80 participants sought
Pennington Biomed Res Ctr — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Novo Nordisk A/S
Using a Steroid Mouthwash to Prevent Mouth Sores During Chemotherapy
Oral Mucositis Due to Chemotherapy
Phase 4
Interventional 45 participants sought
Woman's Hospital — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Woman's
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Louisiana Hematology Oncology Associates LLC — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Phase 3
Interventional 450 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Novartis Pharmaceuticals
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: GlaxoSmithKline